TRC 2004, Inc. has raised $90.0M in total funding. The most recent round was Series B.
TRC 2004, Inc. is headquartered in San Diego, CA.
TRC 2004 was co-founded by Third Rock Ventures and Two River, the same investor group behind Kite Pharma (sold to Gilead for roughly $11.9B), and later emerged publicly as Candid Therapeutics with a $370M capital raise.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.